Jazz Pharmaceuticals plc (J7Z.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 05:42PM CEST. Market open.
| Previous close | 101.25 |
| Open | 101.45 |
| Bid | 102.75 x 1700 |
| Ask | 103.40 x 1700 |
| Day's range | 101.45 - 102.50 |
| 52-week range | 99.06 - 134.35 |
| Volume | |
| Avg. volume | 4 |
| Market cap | 6.543B |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | 23.51 |
| EPS (TTM) | 4.36 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 208.50 |
ZacksJazz (JAZZ) International Revenue Performance Explored
Review Jazz's (JAZZ) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Simply Wall St.Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
Jazz Pharmaceuticals ( NASDAQ:JAZZ ) First Quarter 2024 Results Key Financial Results Revenue: US$902.0m (up 1.0% from...
ZacksJazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
© 2024 Yahoo. All rights reserved.